Latest News & Features
Americas
Merck Serono has failed to convince a US appeals court to overturn a PTAB decision invalidating two dosing regimen patents for cladribine. 4 November 2025
Americas
With AI reshaping IP enforcement, the pharma giant’s IP head warns that only active guidance will stop the industry from lagging behind, reports Muireann Bolger. 3 November 2025
Americas
In his first public remarks since becoming the USPTO director, a bombastic John Squires promises an agency “in overdrive” that's doubling down on AI, reports Sarah Speight. 1 November 2025
Americas
Private practitioners, in-house counsel and IP services from around the world converge in the US capital for the major event, from where Sarah Speight provides on-the-ground coverage. 30 October 2025
Americas
Danish pharma giant sweetens offer for hot peptide therapeutics company, aiming to cement its market position amid an intensifying GLP-1 patent race. 30 October 2025
Americas
With fraudsters exploiting new technologies, the company’s Kenya Williams explains why vigilant enforcement is money well spent to maintain a ‘clean’ brand. 29 October 2025
Asia
China rankings from sister title provide a guide for counsel and clients looking for trademark specialists in a vast but challenging market, from prosecution experts to heavyweight litigators. 29 October 2025
Americas
A US appeals court had good news for the California-based medtech company in a dispute over its Sapien 3 Ultra transcatheter heart valve. 28 October 2025
Europe
The tech is being used to crunch thousands of documents in billion-dollar mediations and emerging as a valuable party at the table, finds Muireann Bolger. 28 October 2025
Americas
As IP plays a more important role in corporate valuations, acquirers are discovering that the biggest risks in life sciences deals aren’t always in the patents—they’re in the code, the algorithms, and the data. A panel at LSPN North America Fall shared why traditional due diligence is no longer enough. 27 October 2025